During the past decade, Seoul National University conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Seoul National University" are "Hepatitis B" (2 trials). Many other conditions were trialed in "Seoul National University" in a lesser frequency.

Most popular intervention types in "Seoul National University" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Clevudine" (1 trials) and "clevudine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Seoul National University" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Seoul National University". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Seoul National University, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Seoul National University, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".